Related content

Prevention and Treatment of Postmenopausal Osteoporosis

By Mahakala Aparna   Thoutreddy Shalini   Kleerekoper Michael  

Treatments in Endocrinology, Vol. 2, Iss. 5, 2003-01 ,pp. : 331-345

Adis International

Access to resources Recommend Favorite

Antiresorptive Therapy for the Prevention of Postmenopausal Osteoporosis: When Should Treatment Begin?

By Vestergaard Peter  

Treatments in Endocrinology, Vol. 4, Iss. 5, 2005-01 ,pp. : 263-277

Adis International

Access to resources Recommend Favorite

The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab

By Capozzi Anna   Lello Stefano   Pontecorvi Alfredo  

Gynecological Endocrinology, Vol. 30, Iss. 6, 2014-06 ,pp. : 403-408

Informa Healthcare

Access to resources Recommend Favorite

Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonates

By Al-Azzawi Farook  

Gynecological Endocrinology, Vol. 24, Iss. 11, 2008-01 ,pp. : 601-609

Informa Healthcare

Access to resources Recommend Favorite

Effects of ipriflavone on postmenopausal syndrome and osteoporosis

By Zhang Xin   Li Shao-Wen   Wu Jin-Fang   Dong Chun-Li   Zheng Cai-Xia   Zhang Yun-Ping   Du Juan  

Gynecological Endocrinology, Vol. 26, Iss. 2, 2010-02 ,pp. : 76-80

Informa Healthcare

Access to resources Recommend Favorite